您好，欢迎访问广东省农业科学院 机构知识库！
广东省农业科学院机构知识库

全部

  • 全部
  • 标题
  • 学者
  • 机构
  • 关键词

The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model

文献类型： 外文期刊

作者： Guo, Shanguang 2 ; Yan, Weiwei 1 ; McDonough, Sean P. 1 ; Lin, Nengfeng 1 ; Wu, Katherine J. 1 ; He, Hongxuan 1 ; Xian 1 ;

作者机构： 1.Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA

2.South China Agr Univ, Coll Food Sci, Guangzhou 510642, Guangdong, Peoples R China

3.Chinese Acad Sci, Inst Zool, Beijing, Peoples R China

4.Guangdong Acad Agr Sci, Vet Inst, Guangzhou, Guangdong, Peoples R China

5.Guizhou Acad Agr Sci, Guizhou Inst Anim Husb & Vet Med, Guiyang, Peoples R China

6.Univ Fed Vicosa, Dept Vet, Sect Med Vet Prevent & Saude Publ 6, Vicosa, MG, Brazil

关键词： Clostridium difficile;Lactococus lactis;TcdA;TcbB;Vaccine trial

期刊名称：VACCINE （ 影响因子：3.641； 五年影响因子：3.816 ）

ISSN：

年卷期：

页码：

收录情况： SCI

摘要： Clostridium difficile infection (CDI) causes nosocomial antibiotic-associated diarrhea and colitis in the developed world. Two potent cytotoxins, toxin A (TcdA) and toxin B (TcdB) are the virulence factors of this disease and can be a good vaccine candidate against CDI. In the present study, we genetically engineered Lactococcus lactis to express the nontoxic, recombinant fragments derived from TcdA and TcdB C-terminal receptor binding domains (Tcd-AC and Tcd-BC) as an oral vaccine candidate. The immunogenicity of the genetically engineered L. lactis oral vaccine delivery system (animal groups LAC and LBC or the combination of both, LACBC) was compared with the recombinant TcdA and TcdB C-terminal receptor binding domain proteins (animal groups PAC and PBC or the combination of both, PACBC), which were expressed and purified from E. coli. After the C. difficile challenge, the control groups received PBS or engineered L lactis with empty vector, showed severe diarrhea symptoms and died within 2-3 days. However, both the oral vaccine and recombinant protein vaccine groups had significantly lower mortalities, body weight decreases and histopathologic lesions than the control sham-vaccine groups (p<0.05) except group LBC which only had a 31% survival rate after the challenge. The data of post infection survival showed that an average of 86% of animals survived in groups PAC and PACBC, 75% of animals survived in group LACBC, and 65% of animals survived in group LAC. All of the vaccinated animals produced higher titers of both IgG and IgA than the control groups (p<0.05), and the antibodies were able to neutralize the cytopathic effect of toxins in vitro. The results of this study indicate that there is a potential to use L. lactis as a delivery system to develop a cost effective oral vaccine against CDI. (C) 2015 Elsevier Ltd. All rights reserved.

  • 相关文献

[1]Equine hyperimmune serum protects mice against Clostridium difficile spore challenge. Yan, Weiwei,Shin, Kang-Soon,Wang, Shih-Jon,Xiang, Hua,Akey, Bruce,Mohamed, Hussni,Chang, Yung-Fu,Divers, Thomas,McDonough, Sean,Wang, Shih-Jon,Xiang, Hua,Bowman, James,Rowlands, Anne.

作者其他论文 更多>>
置顶
购物车
反馈

© 京ICP备09089781号-29 主办单位：广东省农业科学院

学术资源： 中国农业科学院 农业专业知识服务系统 农科联盟资源共建共享平台 中国农业科技文献与信息服务平台 中国农业期刊集成服务平台